Kin KeeperSM: Reducing Disparities Through Cancer Literacy and Screening

Michigan State University1 site in 1 country516 target enrollmentJuly 2010

ConditionsBreast Cancer Cervical Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Breast Cancer
Sponsor: Michigan State University
Enrollment: 516
Locations: 1
Primary Endpoint: First time AND appropriately timed, clinical breast exam, mammogram, pap test
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

To determine if the Kin KeeperSM Cancer Prevention Intervention increases first time and appropriately timed breast cancer screening rates among Black, Latina and Arab women; 2) To determine if the Kin KeeperSM Cancer Prevention Intervention increase first time and appropriately time cervical cancer screening rates among Black, Latina and Arab women; 3) To measure functional cancer literacy over time at the individual and familial level and 4) Assess rates of healthcare utilization cost among women in the Kin KeeperSM intervention and control-comparison groups.

Registry

clinicaltrials.gov

Start Date

July 2010

End Date

June 2015

Last Updated

10 years ago

Study Type

Interventional

Study Design

Parallel

Sex

Female

Investigators

Sponsor

Michigan State University

Responsible Party

Principal Investigator

Karen Williams

Professor

Michigan State University

Eligibility Criteria

Inclusion Criteria

•Participants:self-identified as Black Latina and Arab women ho can recruit at least two bloodline female family members (mother daughter sister, etc.; can accommodate two in-home visits by a community health worker; and 21-70 years of age.

Exclusion Criteria

•are not self-identified as Black, Latina, or Arab; do not have direct bloodline relatives; and are younger than 21 or older than 70 years of age.

Outcomes

Primary Outcomes

First time AND appropriately timed, clinical breast exam, mammogram, pap test

Time Frame: Baseline through 36 months.

Participants will complete measures every 6 months (baseline, 12 mo., 18 mo., 24 mo., 30 mo. \& 36 mo.)to measure increases in screening rates for experimental vs. control group.